A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation

Jessica Castro1, Marc Ribó, Susanna Navarro

  • 1Laboratori d'Enginyeria de Proteïnes, Departament de Biologia, Facultat de Ciències, Universitat de Girona, Campus de Montilivi s/n E-17071 Girona, Spain.

BMC Cancer
|January 13, 2011
PubMed
Abstract

Insights

PE5, a ribonuclease variant, induces cancer cell death via apoptosis, independent of p53 and drug resistance. Its mechanism differs from onconase, involving cell cycle arrest and JNK inactivation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ribonucleases are investigated as anticancer agents.
  • Onconase, a ribonuclease, shows cytotoxic and cytostatic effects and is in clinical trials.
  • PE5, a human pancreatic ribonuclease variant with a nuclear localization signal, is studied for its anticancer potential.

Purpose of the Study:

  • To investigate and compare the cytotoxicity mechanisms of PE5 and onconase.
  • To elucidate the role of apoptosis, cell cycle, and specific protein pathways in PE5-induced cell death.

Main Methods:

  • Cytotoxicity assessed using MTT and trypan blue exclusion assays.
  • Apoptosis evaluated via flow cytometry, caspase activity detection, and confocal microscopy.
  • Cell cycle distribution and protein expression (cyclins, caspases, XIAP, JNK) analyzed by flow cytometry and western blot.

Main Results:

  • PE5 induces apoptosis independently of p53 and multidrug resistance.
  • Both PE5 and onconase exhibit similar cell death extent, but only onconase causes growth arrest.
  • PE5 treatment increases cells in S and G2/M phases, upregulates cyclin E and p21WAF1/CIP1, and inactivates JNK.
  • Onconase does not alter cell cycle distribution but decreases XIAP expression.

Conclusions:

  • PE5 mediates cancer cell death through apoptosis, p21WAF1/CIP1 induction, and JNK inactivation.
  • The cytotoxic mechanism of PE5 is distinct from that of onconase.
  • PE5 represents a promising anticancer agent with a unique mechanism of action.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.